ARCHIVES

Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

HHS Secretary Tommy Thompson announced his resignation.

December 3, 2004

Sales of Smoking Cessation Aids Increase, Effectiveness Drops

October 25, 2002

Sen. Grassley Presses Amgen on “Bundling.”

April 11, 2008

Organizations Ask Senate To Increase NCI Appropriations, Order OMB To “Get Nose Out Of Tent”

May 2, 1986

Letter To the Editor: Screening Revisited

May 20, 1994

MSK Investigators Report Sialic Acid Test 95% Accurate; Negative Immunotherapy Results Told

June 13, 1980